كندا - الإنجليزية - Health Canada

ferring inc - degarelix (degarelix acetate) - powder for solution - 80mg - degarelix (degarelix acetate) 80mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

ferring inc - degarelix (degarelix acetate) - powder for solution - 120mg - degarelix (degarelix acetate) 120mg - antineoplastic agents

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

ferring pharmaceuticals private limited - degarelix acetate 128 mg eqv degarelix - injection, powder, for solution - 120 mg - degarelix acetate 128 mg eqv degarelix 120 mg

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

ferring pharmaceuticals private limited - degarelix acetate 88.2 mg eqv degarelix - injection, powder, for solution - 80 mg - degarelix acetate 88.2 mg eqv degarelix 80 mg

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - degarelix acetate - powder and solvent for solution for injection - 120mg

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - degarelix acetate - powder and solvent for solution for injection - 80mg

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - water for injections, quantity: 4.2 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.